Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insmed (INSM) Revenue (2018 - 2026)

Insmed's Revenue history spans 12 years, with the latest figure at $306.0 million for Q1 2026.

  • Quarterly Revenue rose 229.62% to $306.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $819.6 million through Mar 2026, up 115.09% year-over-year, with the annual reading at $606.4 million for FY2025, 66.73% up from the prior year.
  • Revenue came in at $306.0 million for Q1 2026, up from $263.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $306.0 million in Q1 2026 to a low of $53.1 million in Q1 2022.
  • The 5-year median for Revenue is $83.7 million (2023), against an average of $107.5 million.
  • Year-over-year, Revenue increased 5.66% in 2022 and then surged 229.62% in 2026.
  • Insmed's Revenue stood at $59.3 million in 2022, then surged by 41.13% to $83.7 million in 2023, then increased by 24.79% to $104.4 million in 2024, then skyrocketed by 152.62% to $263.8 million in 2025, then grew by 15.96% to $306.0 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Revenue are $306.0 million (Q1 2026), $263.8 million (Q4 2025), and $142.3 million (Q3 2025).